| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/11/2004 | US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/11/2004 | US20040048828 Immunosuppressive agent and food |
| 03/11/2004 | US20040048820 Prevention or therapy of cardiovascular complications |
| 03/11/2004 | US20040048811 Drynaria extractions for treating osteoporosis and their extraction process |
| 03/11/2004 | US20040048799 Combination therapy using a TNF binding protein for treating TNF-mediated diseases |
| 03/11/2004 | US20040048795 Stimulating a vagus nerve pathway in the brain; inhibiting apoptosis of a cardiac myocyte |
| 03/11/2004 | US20040048772 Preventives for arthritis |
| 03/11/2004 | US20040048325 Glycosyltransferase inhibitors |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048266 Regulation of human membrane-type serine protease |
| 03/11/2004 | US20040048245 Isolated polypeptide of given sequence; identifying modulators by contacting with compound and detecting binding activity; use in diagnosis and treatment |
| 03/11/2004 | US20040047896 Composition for improving age-related physiological deficits and increasing longevity |
| 03/11/2004 | US20040047863 Administering TNF(Tumor necrosis factor) binding protein and at least one additional anti-inflammatory drug, for therapy of an acute or chronic inflammatory disease |
| 03/11/2004 | US20040047860 Antibodies to human mcp-1 |
| 03/11/2004 | US20040047856 Colorstrum-based composition |
| 03/11/2004 | US20040047807 Neurotoxic substances, which have a toxic effect in particular for the axon and the nociceptive nerve endings, for the preparation of an agent for the treatment of joint pain. |
| 03/11/2004 | DE10240343A1 Peroxynitrit-Umlagerungskatalysatoren Peroxynitrite rearrangement catalysts |
| 03/11/2004 | CA2537158A1 Cxcr4 antagonist and use thereof |
| 03/11/2004 | CA2502734A1 Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient |
| 03/11/2004 | CA2496920A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | CA2496523A1 Human antihuman interleukin-6 antibody and fragment of the antibody |
| 03/11/2004 | CA2495914A1 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | CA2495853A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12 |
| 03/11/2004 | CA2495437A1 Novel crystal |
| 03/11/2004 | CA2494754A1 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds |
| 03/11/2004 | CA2493199A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions |
| 03/11/2004 | CA2488739A1 Nitrogen-containing aromatic derivatives |
| 03/10/2004 | EP1396542A2 Novel P-selectin ligand protein |
| 03/10/2004 | EP1396493A1 Heterocyclic compounds |
| 03/10/2004 | EP1396492A1 Prodrug of an ice inhibitor |
| 03/10/2004 | EP1396491A2 2-substituted 4,5-diaryl-imidazoles and their use as p38 MAP kinase inhibitors |
| 03/10/2004 | EP1396487A1 Phenylpyridine carbonyl piperazine derivative |
| 03/10/2004 | EP1396265A1 Ion exchange resins for alleviation of upper gastrointestinal irritation |
| 03/10/2004 | EP1395684A2 New polynucleotides and polypeptides of the ifnalpha-7 gene |
| 03/10/2004 | EP1395652A2 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 03/10/2004 | EP1395582A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 03/10/2004 | EP1395575A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395574A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395568A1 4-aminopyrimidine derivatives |
| 03/10/2004 | EP1395564A1 Quinoline derivatives as ligands for the neuropeptide y receptor |
| 03/10/2004 | EP1395563A1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 03/10/2004 | EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production |
| 03/10/2004 | EP1395559A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395558A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395554A1 Substituted carbazoles as inhibitors of spla2 |
| 03/10/2004 | EP1395538A1 Vitamin d analogues |
| 03/10/2004 | EP1395285A2 Reagents and methods for modulating dkk-mediated interactions |
| 03/10/2004 | EP1395277A1 The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis |
| 03/10/2004 | EP1395269A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 03/10/2004 | EP1395268A1 A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation |
| 03/10/2004 | EP1395259A2 Urazole compounds useful as anti-inflammatory agents |
| 03/10/2004 | EP1395242A1 Liquid pharmaceutical composition |
| 03/10/2004 | EP1081132B1 Hydroxamic acid derivatives and medicinal utilization thereof |
| 03/10/2004 | EP1066044B1 Dextran formulations for treatment of inflammatory joint disorders |
| 03/10/2004 | EP0983256B1 Triptolide derivatives useful in the treatment of autoimmune diseases |
| 03/10/2004 | CN1481390A Immunomodulatory peptidesderived from heat shock proteins and uses thereof |
| 03/10/2004 | CN1481377A Cyclic Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF alhpa |
| 03/10/2004 | CN1481372A 1,1-dioxo-2H-1,2-benzothiazine-3-carboxamide derivatives, method for preparing same and pharmaceutical compsns comprising same |
| 03/10/2004 | CN1481367A Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 03/10/2004 | CN1481364A Urea and urethane derivatives as integrin inhibitors |
| 03/10/2004 | CN1481247A Use of zolendronate for mfg. medicament for treatment of bone metabolism diseases |
| 03/10/2004 | CN1481238A Aniline derivatives or salts thereof and cytokine prodn inhibitors contg. same |
| 03/10/2004 | CN1480217A Medicinal preparation and its prepn. and application |
| 03/10/2004 | CN1480210A Usage of leptin for promoting healing of wound |
| 03/10/2004 | CN1480207A Spore of gandoderma lucidum for treating disease of autoimmunity |
| 03/10/2004 | CN1480201A Formula of medication for treating bone fracture and contuse |
| 03/10/2004 | CN1480196A Powder preparations for treating allied rheumatism |
| 03/10/2004 | CN1480185A Prepared Chinese external medicine for reducing swelling and ease pain |
| 03/10/2004 | CN1480184A Prepared Chinese internal medicine of notoginseng for promoting blood circulation |
| 03/10/2004 | CN1480183A Prepared Chinese internal medicine for promoting blood circulation to stop pain |
| 03/10/2004 | CN1480182A Prepared Chinese internal medicine for treating hyperosteogeny |
| 03/10/2004 | CN1480181A Prepared Chinese internal medicine of 'healthy femur' |
| 03/10/2004 | CN1480180A Prepared Chinese internal medicine for treating prolapse of intervertebral disc |
| 03/10/2004 | CN1480175A Pills for promoting reunion of bone, muscle and ligament |
| 03/10/2004 | CN1480142A compound preparation composed of longspur epimedium and estrogen for treating osteoporosis of women after climacteric |
| 03/10/2004 | CN1141127C Medicine for treating protrusion of cervical and lumbar intervertebral disc |
| 03/10/2004 | CN1141123C Medicine for treating rheumatism, rheumatoid disease, lumbar intervertebra disk protrusion, hyperosteogeny and ischias and its prepn process |
| 03/10/2004 | CN1141119C Capsule for treating atrophic arthritis and its prodn method |
| 03/10/2004 | CN1141117C Wine for treating injury |
| 03/10/2004 | CN1141114C Tendon-conditioning analgesic preparation |
| 03/10/2004 | CN1141111C Far infrared gukangtie plaster and its prepn technique |
| 03/10/2004 | CN1141108C Externally-used powder for curing rheumatism involving bone and its preparation method |
| 03/10/2004 | CN1141092C Composition for preventing and treating osteoporosis and cancer and decreasing decreasing blood fat and its application |
| 03/09/2004 | US6703444 Contacting with crosslinking agents so as to form two or more chemically distinct crosslinks between hyaluronic acid and the polymer; products with medical applications |
| 03/09/2004 | US6703377 Viscosity; biodegradability; fibroblast growth factor |
| 03/09/2004 | US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 03/09/2004 | US6703049 Angiogenesis inhibitor |
| 03/09/2004 | CA2272463C Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives |
| 03/09/2004 | CA2260016C Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 03/05/2004 | CA2437690A1 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 03/04/2004 | WO2004018669A1 Salt-inducible kinases 2 and use thereof |
| 03/04/2004 | WO2004018491A1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 03/04/2004 | WO2004018469A1 Novel purine derivatives, production and use thereof as medicaments |
| 03/04/2004 | WO2004018458A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 03/04/2004 | WO2004018457A1 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
| 03/04/2004 | WO2004018451A1 Pyridazinone-derivatives as pde4 inhibitors |
| 03/04/2004 | WO2004018435A1 Pyrimidine derivatives as modulators of chemokine receptor activity |
| 03/04/2004 | WO2004018434A1 Pyrimidine compounds |
| 03/04/2004 | WO2004018431A2 Novel phenanthridines |
| 03/04/2004 | WO2004018430A1 COMPOUND HAVING TGFß INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME |